Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080

Cancer Research

Volumn 55, Issue 13, 1995, Pages 2927-2935

  Tanaka, Kazuhiro ^a   Iwamoto, Yukihide ^a   Ito, Yasumasa ^a   Ishibashi, Toru ^a   Nakabeppu, Yusaku ^b   Sekiguchi, Mutsuo ^b   Sugioka, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; CYCLIC AMP; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMAL; BASE SEQUENCE; COLLAGEN; COLLAGENASES; CYCLIC AMP; DNA PRIMERS; FEMALE; FIBROSARCOMA; GELATINASE A; GELATINASE B; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; IN VITRO; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTEIN KINASES; PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE INHIBITOR-OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0029043226     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Liotta, L. A., Rao, C. N., and Wewer, U. M. Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 55:1037–1057, 1986.
2. Stetler-Stevenson, W. G., Liotta, L. A., and Kleiner, D. E., Jr. Extracellular matrix 6:role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7:1434–1441, 1993.
3. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. Matrix metalloproteinases:a review. Crit. Rev. Oral Biol. Med., 4:197–250, 1993.
4. Woessner, J. F., Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5:2145–2154, 1991.
5. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M.M. and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284:67–68, 1980.
6. Nakajima, M., Welch, D. R., Belloni, P. N., and Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47:4869–4876, 1987.
7. Reich, R., Thompson, E. W., Iwamoto, Y., Martin, G. R., Deason, J. R., Fuller, G. C., and Miskin, R. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membrane by metastatic cells. Cancer Res., 48:3307–3312, 1988.
8. Bernhard, E. J., Muschel, R. J., and Hughes, E. N. Mr 92, 000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50:3872–3877, 1990.
9. Levy, A. T., Cioce, V., Sobel, M. E., Garbisa, S., Grigioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. Increased expression of the AMr 72, 000 type IV collagenase in human colonic adenocarcinoma. Cancer Res., 57:439–444, 1991.
10. Stearns, M., and Wang, M. Type IV collagenase (Mr 72, 000) expression in human prostate:benign and malignant tissue. Cancer Res., 53:878–883, 1993.
11. Yamagata, S., Ito, Y., Tanaka, R., and Shimizu, S. Gelatinases of metastatic cell lines of murine colonic carcinoma detected by substrate-gel electrophoresis. Biochem. Biophys. Res. Commun., 151:158–162, 1988.
12. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53:140–146, 1993.
13. Clark, S. D., Kobayashi, D. K., and Welgus, H. G. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest., 80:1280–1288, 1987.
14. Kerr, L. D., Miller, D. B., and Matrisian, L. M. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell, 61:267–278, 1990.
15. MacNaul, K. L., Chartrain, N., Lark, M., Tocci, M. J., and Hutchinson, N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. J. Biol. Chem., 265:17238–17245, 1990.
16. He, C., Wilhelm, S. M., Pentland, A. P., Manner, B. L., Grant, G. A., Eisen, A. Z., and Goldberg, G. I. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA, 86:2632–2636, 1989.
17. Nagase, H., Enghild, J. J., Suzuki, K., and Salvesen, G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry, 29:5783–5789, 1990.
18. Stetler-Stevenson, W. G., Krutzsch, H. C., Wacher, M. P., Margulies, I. M. K., and Liotta, L. A. The activation of human type IV collagenase proenzyme:sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem., 264:1353–1356, 1989.
19. Windsor, L. J., Birkedal-Hansen, H., Birkedal-Hansen, B., and Engler, J. A. An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry, 30:641–647, 1991.
20. Khokha, R., and Denhardt, D. T. Matrix metalloproteinases and tissue inhibitor of metalloproteinases:a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis, 9:391–405, 1989.
21. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation. Cell, 64:327–336, 1991.
22. Matrisian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6:121–125, 1990.
23. Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., and Reynolds, J. J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (Lond.), 318:66–69, 1985.
24. Pavloff, N., Staskus, P. W., Kishnani, N. S., and Hawkes, S. P. A new inhibitor of metalloproteinases from chicken:ChIMP-3, a third member of the TIMP family. J. Biol. Chem., 267:17321–17326, 1992.
25. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2):a new member of the metalloproteinase inhibitor family. J. Biol. Chem., 264:17374–17378, 1989.
26. Howard, E. W., Bullen, E. C., and Banda, M. J. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J. Biol. Chem., 266:13070–13075, 1991.
27. Goldberg, G. I., Manner, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. M., and He, C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA, 86:8207–8211, 1989.
28. Wilhelm, S. M., Collier, I. E., Manner, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264:17213–17221, 1989.
29. Alvarez, O. A., Carmichael, D. F., and DeClerck, Y. A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human inhibitor of metalloproteinases. J. Natl. Cancer Inst., 82:589–595, 1990.
30. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52:701–708, 1992.
31. Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., and Denhardt, D. T. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (Washington DC), 243:947–950, 1989.
32. Khokha, R., Zimmer, M. J., Graham, C. H., Lala, P. K., and Waterhouse, P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst., 84:1017–1022, 1992.
33. Mignatti, P., Robbins, E., and Rifkin, D. B. Tumor invasion through the human amniotic membrane:requirement for a proteinase cascade. Cell, 47:487–498, 1986.
34. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., and Carmichael, D. F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res., 48:5539–5545, 1988.
35. Tsuchiya, Y., Sato, H., Endo, Y., Okada, Y., Mai, M., Sasaki, T., and Seiki, M. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res., 53:1397–1402, 1993.
36. Friedman, D. L. Role of cyclic nucleotides in cell growth and differentiation. Physiol. Rev., 56:652–708, 1976.
37. Pastan, I. H., Johnson, G. S., and Anderson, W. B. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem., 44:491–522, 1975.
38. Prasad, K. N. Differentiation of neuroblastoma cells in culture. Biol. Rev., 50:129–165, 1975.
39. Hill, S. E., Rees, R. C., and MacNeil, S. A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma. Clin. Exp. Metastasis, 8:461–474, 1990.
40. Sheppard, J. R., Koestler, T. P., Corwin, S. P., Buscarino, G., Doll, J., Lester, B., Greig, R. G., and Poste, G. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature (Lond.), 308:544–547, 1984.
41. Vos, H. D., Verschueren, H., Convents, A., De Baetselier, P., and Vauquelin, G. Cyclic AMP content and invasive capacity of metastatic variants of the BW5147 murine T-cell lymphoma. Life Sci., 46:497–505, 1990.
42. Agarwal, K. C., and Parks, R. E., Jr. Forskolin:a potential antimetastatic agent. Int. J. Cancer, 32:801–804, 1983.
43. Iwamoto, Y., Reich, R., Nemeth, G., Yamada, Y., and Martin, G. R. Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transfected mouse fibroblasts. Clin. Exp. Metastasis, 11:492–501, 1993.
44. Ormerod, E. J., and Hart, I. R. Different growth response to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity. Clin. Exp. Metastasis, 7:85–95, 1989.
45. Okuyama, K., Iwamoto, Y., Tanaka, K., Ito, Y., and Sugioka, Y. The inhibition of the invasion of human fibrosarcoma cells by cyclic AMP analogues and cholera toxin. Cancer J., 7; 150–157, 1994.
46. Horton, J. K., Martin, R. C., Kalinka, S., Cushing, A., Kitcher, J. P., O'Sullivan, M. J., and Baxendale, P. M. Enzyme immunoassays for the estimation of adenosine 3′, 5′ cyclic monophosphate and guanosine 3′, 5′ cyclic monophosphate in biological fluids. J. Immnunol. Methods, 155:31–40, 1992.
47. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18:5294–5299, 1979.
48. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A., and Liotta, L. A. Tissue inhibitor of metalloproteinases-2 (TTMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem., 265:13935-13938, 1990.
49. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-trans-formed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem., 263:6579–6587, 1988.
50. Studier, F. W., Rosenberg, A H., Dunn, J. J., and Dubendorff, J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol., 185:60–89, 1990.
51. Nakabeppu, Y., and Nathans, D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell, 64:751–759, 1991.
52. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47:3239–3245, 1987.
53. Iwamoto, Y., and Sugioka, Y. Use of reconstituted basement membrane to study the invasiveness of tumor cells. Adv. Exp. Med. Biol., 324:141–149, 1992.
54. Iwamoto, Y., Tanaka, K., Okuyama, K., Sugioka, Y., and Taniguchi, S. In vitro assay of the invasive potential of malignant bone and soft tissue tumors through basement membranes. Int. Orthop., 18:240–247, 1994.
55. Nakajima, M., Lotan, D., Baig, M. M., Carralero, R. M., Wood, W. R., Hendrix, M. J. C., and Lotan, R. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res., 49:1698–1706, 1989.
56. Sambrook, J., Fritsch, E. F., and Maniatis, T. Extraction, purification and analysis of messenger RNA from eukaryotic cells. In:C. Noran (ed.), Molecular Cloning:A Laboratory Manual, pp. 7.1–7.87. Cold Spring Harbor, New York:Cold Spring Harbor Laboratory, 1989.
57. Nakabeppu, Y., Oda, S., and Sekiguchi, M. Proliferative activation of quiescent Rat-IA cells by AFosB. Mol. Cell. Biol., 13:4157–4166, 1993.
58. Deutsch, P. J., Jameson, J. L., and Habener, J. E. Cyclic AMP responsiveness of human gonadotropin-α gene transcription is directed by a repeated 18-base pair enhancer:a-promoter receptivity to the enhancer confers cell-preferential expression. J. Biol. Chem., 262:12169–12174, 1987.
59. Hoeffler, J. P., Meyer, T. E., Yun, Y., Jameson, J. L., and Habener, J. F. Cyclic AMP-responsive DNA-binding protein:structure based on a cloned placental cDNA. Science (Washington DC), 242:1430–1433, 1988.
60. Picado-Leonard, J., Voutilainen, R., Kao, L., Chung, B., Strauss, J. F., III, and Miller, W. L. Human adrenotoxin:cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. J. Biol. Chem., 263:3240–3244, 1988.
61. Imagawa, M., Chiu, R., and Karin, M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways:protein kinase C and cAMP. Cell, 51:251–260, 1987.
62. Campbell, C. E., Flenniken, A. M., Skup, D., and Williams, B. R. G. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem., 266:7199–7206, 1991.
63. DeClerck, Y. A., Darville, M. I., Eeckhout, Y., and Rousseau, G. G. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene (Amst.), 139:185–191, 1994.
64. Frisch, S. M., and Morisaki, J. H. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol., 10:6524–6532, 1990.
65. Sato, H., and Seiki, M. Regulatory mechanism of 92kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8:395–405, 1993.
66. Nakamura, T., Datta, R., Sherman, M. L., and Kufe, D. Regulation of c-jun gene expression by cAMP in HL-60 myeloid leukemia cells. J. Biol. Chem., 265:22011–22015, 1990.
67. Chiu, R., Boyle, W., Meek, J., Smeal, T., Hunter, T., and Karin, M. The fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell, 54:541–552, 1988.
68. Cho-Chung, Y. S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy:new approaches to therapy. Cancer Res., 50:7093–7100, 1990.
69. Yokozaki, H., Tortora, G., Pepe, S., Maronde, E., Genieser, H. G., Jastorff, B., and Cho-Chung, Y. S. Unhydrolyzable analogues of adenosine 3′:5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res., 52:2504–2508, 1992.
70. Slungaard, A., Confer, D. L., and Schubach, W. H. Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate-promoted differentiation of leukemic cells. J. Clin. Invest., 79:1542–1547, 1987.
71. Trepel, J. B., Colamonici, O. R., Kelly, K., Schwab, G., Watt, R. A., Sausville, E. A., Jaffe, E. S., and Neckers, L. M. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells. Mol. Cell. Biol., 7:2644–2648, 1987.
72. Bang, Y. J., Kim, S. J., Danielpour, D., O'Reilly, M. A., Kim, K. Y., Myers, C. E., and Trepel, J. B. Cyclic AMP induces transforming growth factor β2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc. Natl. Acad. Sci. USA, 89:3556–3560, 1992.